35 innovative, mission-driven organizations and changemakers selected from nearly 3,000 applicants across more than 120 countries RESTON, Va., Aug. 12,…
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R),…
MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR,…
HANOI, Vietnam, Aug. 11, 2025 /PRNewswire/ -- With excitement growing for the 2026 FIFA World Cup, JBO Vietnam is proud to…
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to…
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am…
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…
August 08, 2025 17:00 ET | Source: TELA Bio, Inc. MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio,…
Company will announce second quarter 2025 financial results and host a conference call on August 14, 2025 August 08, 2025…
MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology…